Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Loading NVLS News...
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.46% | 73.76 | 0.9% | $699.22m | |
| AMGN | Amgen Inc. | 0.50% | 180.21 | 1.1% | $562.99m | |
| CELG | Celgene Corporation | 1.05% | 137.74 | 1.1% | $511.41m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.00% | 515.92 | 2.7% | $478.88m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.41% | 163.17 | 1.9% | $401.70m | |
| BIIB | Biogen Inc. | 0.53% | 282.92 | 1.2% | $362.26m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.53% | 131.79 | 1.9% | $271.34m | |
| TSRO | TESARO, Inc. | 2.29% | 131.97 | 14.7% | $172.59m | |
| ILMN | Illumina, Inc. | 0.45% | 172.75 | 3.5% | $161.08m | |
| INCY | Incyte Corporation | 0.32% | 134.22 | 2.6% | $151.82m | |
| EXEL | Exelixis, Inc. | 0.89% | 27.23 | 6.5% | $148.60m | |
| CLVS | Clovis Oncology, Inc. | 1.61% | 86.64 | 18.0% | $130.90m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.76% | 89.28 | 4.4% | $127.08m | |
| KITE | Kite Pharma, Inc. | -0.67% | 109.15 | 16.1% | $120.98m | |
| SRPT | Sarepta Therapeutics, Inc. | 6.06% | 43.41 | 19.8% | $112.50m |
Company Profile
Nivalis Therapeutics, Inc. is a clinical stage pharmaceutical company, which engages in discovery, development, and commercialization of product for patients with cystic fibrosis. Its product includes N91115, a small molecule that addresses a defect in the cystic fibrosis transmembrane conductance regulator. The company was founded in 2008 and is headquartered in Boulder, CO.